Skip to Main
freight train with containers

Equities

Oppenheimer’s Equities Department strives to create exceptional value for our corporate and institutional clients. Our goal is to be the premier research, trading, and capital solutions firm for the markets we serve.

Our core capabilities include:

  • A research department of more than 100 research professionals providing coverage of over 500 companies across a wide range of industries, with a particular focus on mid- and small-cap companies
  • Over 100 institutional sales professionals operating throughout the U.S., U.K., Israel, Asia, and Europe through various affiliates
  • A global trading platform that provides execution in all venues and on numerous exchanges throughout the world
  • An Equity Capital Markets Group that offers innovative and comprehensive capital markets solutions

In addition to these capabilities, we offer specialized service and expertise in basket trading, event and merger arbitrage, convertible securities, and institutional options/ETFs.

August 2018

$40,000,008

  • IPO
  • Lead Bookrunner
  • Vaccinex, Inc
  • Healthcare